Arcus Biosciences
RCUS
RCUS
157 hedge funds and large institutions have $1.59B invested in Arcus Biosciences in 2022 Q1 according to their latest regulatory filings, with 34 funds opening new positions, 44 increasing their positions, 55 reducing their positions, and 19 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more first-time investments, than exits
New positions opened: | Existing positions closed:
more funds holding in top 10
Funds holding in top 10: →
more funds holding
Funds holding: →
1.11% less ownership
Funds ownership: 72.35% → 71.25% (-1.1%)
20% less repeat investments, than reductions
Existing positions increased: 44 | Existing positions reduced: 55
23% less capital invested
Capital invested by funds: $2.06B → $1.59B (-$468M)
Holders
157
Holding in Top 10
8
Calls
$23.4M
Puts
$11.1M
Top Buyers
| 1 | +$32.4M | |
| 2 | +$28.8M | |
| 3 | +$17.8M | |
| 4 |
State Street
Boston,
Massachusetts
|
+$17.6M |
| 5 |
PA
Perceptive Advisors
New York
|
+$12.8M |
Top Sellers
| 1 | -$71.3M | |
| 2 | -$45.6M | |
| 3 | -$37.4M | |
| 4 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$15M |
| 5 |
Franklin Resources
San Mateo,
California
|
-$13.5M |